Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Matrix metalloproteinases (MMPs) are a large family of zinc-dependent endopeptidases responsible for the degradation and remodeling of all components of the extracellular matrix (ECM). They play essential roles in normal physiological processes such as embryonic development, wound repair, and tissue morphogenesis by modulating the cellular microenvironment and releasing sequestered growth factors. In pathological states, dysregulated MMP activity is a hallmark of cancer progression, facilitating tumor invasion and metastasis by breaking down basement membranes and promoting angiogenesis. They are also heavily implicated in chronic inflammatory diseases, cardiovascular remodeling, and neurodegenerative disorders. While numerous small-molecule inhibitors were developed to target MMPs for cancer therapy, most failed in clinical trials due to poor selectivity and musculoskeletal toxicity, leading to a shift toward developing highly specific antibodies and allosteric inhibitors.
Inhibition of the zinc-dependent catalytic domain to prevent proteolytic cleavage of extracellular matrix substrates and signaling molecules.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Matrix metalloproteinases (MMPs).